1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Cobolimab with dostarlimab and docetaxel for treating advanced non-small-cell lung cancer after anti-PD-L1 treatment and chemotherapy [ID6398]

In development [GID-TA11500] Expected publication date: TBC

  • Project information
  • Project documents

NIHRIO BN: 30985-Cobolimab-Dostarlimab-Docetaxel-for-Advanced-Non-Small-Cell-Lung-Cancer-V1.0-DEC2023-NON-CONF.pdf (nihr.ac.uk)